For multinational companies eager to cut corners, India is a favourable destination for human clinical trials, since it offers an attractive package of weak laws, lax and almost non-existent oversight of trials, a huge illiterate, vulnerable population that can be easily exploited, very little volunteer protection and a sizeable number of unscrupulous doctors willing to compromise on ethics for gain.
The Hindu : Opinion / Editorial : Clinical trials in the dock: "Having amended the patent laws in 2005 to make India an even more attractive destination for trials, the government is duty-bound to put in place a proper regulatory and monitoring mechanism that would prevent unethical trials from being initiated and flagrant violations from taking place."
Doctors and companies earning handsome profits by throwing ethics and procedures to the winds and turning vulnerable people into guinea pigs will then, hopefully, become a thing of the past.
Doctors and companies earning handsome profits by throwing ethics and procedures to the winds and turning vulnerable people into guinea pigs will then, hopefully, become a thing of the past.
No comments:
Post a Comment
To check spam, comments on older posts are moderated, so expect some delay before your comments are published